Table 2.
Extent of CD44s expression | P-value | ||
---|---|---|---|
Negative or weak (< 25 %)a (n = 53) | Moderate or dense (≥ 25 %)a (n = 41) | ||
Liver metastasis | 16 (30 %) | 9 (22 %) | 0.481 |
Locoregional recurrence | 20 (38 %) | 14 (34 %) | 1.000 |
Peritoneal carcinomatosis | 7 (13 %) | 4 (10 %) | 0.754 |
Bone metastasis | 9 (17 %) | 1 (2 %) | 0.039 |
Other metastasis b | 7 (13 %) | 4 (10 %) | 0.752 |
Total a,c | 35 (66 %) | 25 (61 %) | 0.668 |
aExcludes three patients who died due to surgical complications and one patient with stage IV disease during surgery
bIncluding brain, lung, and ovary metastases
cSome patients developed more than one kind of metastases